Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6
作者： Ulrich M. Zanger , Joachim Fischer , Sebastian Raimundo , Thomas Stüven , Bernd O. Evert
DOI: 10.1097/00008571-200110000-00004
关键词:
摘要: … To investigate functional differences between the detected variant protein forms CYP2D6.1, 2D6.2, 2D6.9 and 2D6.10, we expressed them recombinantly in insect cells. The most …
lww.com
sci-hub.se 参考文章(44)
Ulrich M. Zanger, Immunoisolation of human microsomal cytochromes P450 using autoantibodies Methods in Enzymology. ,vol. 206, pp. 201- 209 ,(1991) , 10.1016/0076-6879(91)06091-G
M Kagimoto, M Heim, K Kagimoto, T Zeugin, U A Meyer, Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes. Journal of Biological Chemistry. ,vol. 265, pp. 17209- 17214 ,(1990) , 10.1016/S0021-9258(17)44890-3
C Sachse, S Bauer, J Brockmöller, I Roots, Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. American Journal of Human Genetics. ,vol. 60, pp. 284- 295 ,(1997)
U A Meyer, M Blum, R Gaedigk, A Gaedigk, M Eichelbaum, Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. American Journal of Human Genetics. ,vol. 48, pp. 943- 950 ,(1991)
U A Meyer, S Kimura, R C Skoda, F J Gonzalez, M Umeno, The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. American Journal of Human Genetics. ,vol. 45, pp. 889- 904 ,(1989)
M. Ingelman-Sundberg, F. Sjoqvist, L. Bertilsson, I. Johansson, Qun-Ying Yue, M. Oscarson, Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Molecular Pharmacology. ,vol. 46, pp. 452- 459 ,(1994)
M Ingelman-Sundberg, F Sjöqvist, L Bertilsson, I Johansson, M L Dahl, Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. Journal of Pharmacology and Experimental Therapeutics. ,vol. 274, pp. 516- 520 ,(1995)
B Osikowska-Evers, P Dayer, U A Meyer, G M Robertz, M Eichelbaum, Evidence for altered catalytic properties of the cytochrome P-450 involved in sparteine oxidation in poor metabolizers Clinical Pharmacology and Therapeutics. ,vol. 41, pp. 320- 325 ,(1987) , 10.1038/CLPT.1987.34
Rachel Tyndale, Toshifumi Aoyama, Franck Broly, Tamihide Matsunaga, Tadanobu Inaba, Werner Kalow, Harry V. Gelboin, Urs A. Meyer, Frank J. Gonzalez, Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype. Pharmacogenetics. ,vol. 1, pp. 26- 32 ,(1991) , 10.1097/00008571-199110000-00005
F. Broly, U. A. Meyer, Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene. Pharmacogenetics. ,vol. 3, pp. 123- 130 ,(1993) , 10.1097/00008571-199306000-00001